The genotype-to-phenotype dilemma: How should laboratories approach discordant susceptibility results?

Rebecca Yee, Jennifer Dien Bard, Patricia J. Simner

Research output: Contribution to journalReview articlepeer-review


Traditional culture-based methods for identification and antimicrobial susceptibility testing (AST) of bacteria take 2 to 3days on average. Syndromic molecular diagnostic panels have revolutionized clinical microbiology laboratories as they can simultaneously identify an organism and detect some of the most significant antimicrobial resistance (AMR) genes directly from positive blood culture broth or from various specimen types (e.g., whole blood, cerebrospinal fluid, and respiratory specimens). The presence or absence of an AMR marker associated with a particular organism can be used to predict the phenotypic AST results to more rapidly guide therapy. Numerous studies have shown that genotypic susceptibility predictions by syndromic panels can improve patient outcomes. However, an important limitation of AMR marker detection to predict phenotype is the potential discrepancies that may arise upon performing phenotypic AST of the recovered organism in culture. The focus of this minireview is to address how clinical laboratories should interpret rapid molecular results from commercial platforms in relation to phenotypic AST. Stepwise approaches and solutions are provided to resolve discordant results between genotypic and phenotypic susceptibility results.

Original languageEnglish (US)
Article numbere00138-20
JournalJournal of clinical microbiology
Issue number6
StatePublished - Jun 2021


  • Antimicrobial resistance
  • Antimicrobial susceptibility testing
  • Molecular methods
  • Predictions

ASJC Scopus subject areas

  • Microbiology (medical)


Dive into the research topics of 'The genotype-to-phenotype dilemma: How should laboratories approach discordant susceptibility results?'. Together they form a unique fingerprint.

Cite this